Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Ruciński, Antoni ^a   Bauer, Julia ^a   Campbell, Patrick ^b   Brons, Stephan ^a   Unholtz, Daniel ^a   Habl, Gregor ^a   Herfarth, Klaus ^a   Debus, Jürgen ^a   Bert, Christoph ^c   Parodi, Katia ^a   Jäkel, Oliver ^a   Haberer, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Augmenix Inc   (United States)

^c GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

Author keywords

Particle therapy; Prostate cancer; Radiation therapy; Spacer gel

Indexed keywords

ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; GEL; HUMAN; MALE; PARTICLE RADIATION; PATIENT SAFETY; POSITRON EMISSION TOMOGRAPHY; PROSTATE; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; SPACER GEL; TREATMENT PLANNING;

GELS; HEAVY ION RADIOTHERAPY; HUMANS; MALE; PHANTOMS, IMAGING; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; PROTON THERAPY; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 84878493271     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-134     Document Type: Article

References (26)

1. Dearnaley D, Hall E, Jackson C, Lawrence D, Huddart R, Eeles R, Gadd J, Warrington A, Bidmead M, Horwich A. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer PSA control and side effects. Brit J Cancer 2005, 92(3):488-498. 2362084, 15685244.
2. Kuban D, Tucker S, Dong L, Starkschall G, Huang E, Cheung M, Lee A, Pollack A. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(1):67-74. 10.1016/j.ijrobp.2007.06.054, 17765406.
3. Schardt D, Elsässer T, Schulz-Ertner D. Heavy-ion tumor therapy: Physical and radiobiological benefits. Rev Mod Phys 2010, 82:383-425.
4. Peschke P, Karger CP, Scholz M, Debus J, Huber PE. Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat. Int J Radiat Oncol Biol Phys 2011, 79:239-246. [http://www.sciencedirect.com/science/article/pii/S0360301610029500], 10.1016/j.ijrobp.2010.07.1976, 20934276.
5. Beltran C, Herman MG, Davis BJ. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 2008, 70:289-295. [http://www.sciencedirect.com/science/article/pii/S0360301607039909], 10.1016/j.ijrobp.2007.08.040, 17919837.
6. Bylund KC, Bayouth JE, Smith MC, Hass AC, Bhatia SK, Buatti JM. Analysis of interfraction prostate motion using megavoltage cone beam computed tomography. Int J Radiat Oncol Biol Phys 2008, 72(3):949-956tt. [http://www.sciencedirect.com/science/article/pii/S036030160802974X], 10.1016/j.ijrobp.2008.07.002, 19014783.
7. Ghilezan MJ, Jaffray DA, Siewerdsen JH, Herk MV, Shetty A, Sharpe MB, Jafri SZ, Vicini FA, Matter RC, Brabbins DS, Martinez AA. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62(2):406-417. [http://www.sciencedirect.com/science/article/pii/S0360301603022120], 10.1016/j.ijrobp.2003.10.017, 15890582.
8. Rietzel E, Bert C. Respiratory motion management in particle therapy. Med Phys 2010, 37(2):449-460. [http://link.aip.org/link/?MPH/37/449/1], 10.1118/1.3250856, 20229853.
9. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes. Int J Radiat Oncol Biol Phys 2005, 63(5):1463-1468. [http://www.sciencedirect.com/science/article/pii/S0360301605009661], 10.1016/j.ijrobp.2005.05.054, 16169683.
10. Tsuji H, Yanagi T, Ishikawa H, Kamada T, Etsu Mizoe J, Kanai T, Morita S, Tsujii H Hypofractionated radiotherapy with carbon ion beams for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 63(4):1153-1160. [http://www.sciencedirect.com/science/article/pii/S0360301605007091], 10.1016/j.ijrobp.2005.04.022, 15990247, Tsujii H.
11. Pinkawa M, Corral NE, Caffaro M, Piroth MD, Holy R, Djukic V, Otto G, Schoth F, Eble MJ. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 2011, 100(3):436-441. [http://www.sciencedirect.com/science/article/pii/S0167814011005317]. [Special Issue on Medical Physics and Brachytherapy], 10.1016/j.radonc.2011.09.005, 21963289.
12. Krämer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization. Phys Med Biol 2000, 45(11):3299. [http://stacks.iop.org/0031-9155/45/i=11/a=313], 10.1088/0031-9155/45/11/313, 11098905.
13. Schneider U, Pedroni E, Lomax A. The calibration of CT Hounsfield units for radiotherapy treatment planning. Phys Med Biol 1996, 41:111. [http://stacks.iop.org/0031-9155/41/i=1/a=009], 10.1088/0031-9155/41/1/009, 8685250.
14. Rietzel E, Schardt D, Haberer T. Range accuracy in carbon ion treatment planning based on CT-calibration with real tissue samples. Radiat Oncol 2007, 2:14. [http://www.ro-journal.com/content/2/1/14], 10.1186/1748-717X-2-14, 1858700, 17381831.
15. Bauer J, Unholtz D, Sommerer F, Kurz C, Haberer T, Herfarth K, Welzel T, Combs S, Debus J, Parodi K. Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment. Radiother Oncol 2012,
16. Paganetti H, Shih HA, Michaud S, Loeffler JS, DeLaney TF, Liebsch NJ, Munzenrider JE, Fischman AJ, Knopf A, Bortfeld T, Parodi K Patient study of In Vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys 2007, 68(3):920-934. [http://www.sciencedirect.com/science/article/pii/S036030160700377X], 10.1016/j.ijrobp.2007.01.063, 2047826, 17544003, Parodi K.
17. Knopf A, Parodi K, Bortfeld T, Shih HA, Paganetti H. Systematic analysis of biological and physical limitations of proton beam range verification with offline PET/CT scans. Phys Med Biol 2009, 54(14):4477. [http://stacks.iop.org/0031-9155/54/i=14/a=008], 10.1088/0031-9155/54/14/008, 19556685.
18. Jäkel O, Jacob C, Schardt D, Karger C, Hartmann G Relation between carbon ion ranges and x-ray CT numbers. Med Phys 2001, 28(4). Hartmann G.
19. Jakoby BW, Bercier Y, Conti M, Casey ME, Bendriem B, Townsend DW. Physical and clinical performance of the mCT time-of-flight PET/CT scanner. Phys Med Biol 2011, 56(8):2375. [http://stacks.iop.org/0031-9155/56/i=8/a=004], 10.1088/0031-9155/56/8/004, 21427485.
20. Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res Sect A: Accelerators, Spectrometers, Detectors Assoc Equip 1993, 330(1-2):296-305. [http://www.sciencedirect.com/science/article/pii/016890029391335K].
21. Battistoni G, Muraro S, Sala P, Cerutti F, Ferrari A, Roesler S, Fassó A, Ranft J. The FLUKA code: Description and benchmarking. AIP Conf Proc 2007, 896:31-49.
22. Fassó A, Ferrari A, Ranft J, Sala P. FLUKA: a multi-particle transport code. Tech. rep., CERN-2005-10, INFN/TC_05/11, SLAC-R-773 2005.
23. Parodi K, Ferrari A, Sommerer F, Paganetti H. Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code. Phys Med Biol 2007, 52(12):3369. [http://stacks.iop.org/0031-9155/52/i=12/a=004], 10.1088/0031-9155/52/12/004, 2292644, 17664549.
24. Parodi K, Mairani A, Brons S, Hasch BG, Sommerer F, Naumann J, Haberer T, Debus J, Jäkel O Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility. Phys Med Biol 2012, 57(12):3759. [http://stacks.iop.org/0031-9155/57/i=12/a=3759], 10.1088/0031-9155/57/12/3759, 22617050, Jäkel O.
25. Pinkawa M, Piroth MD, Holy R, Escobar-Corral N, Caffaro M, Djukic V, Klotz J, EbleK MJ. Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall. Radiother Oncol 2013, 106(2):220-224. [http://www.sciencedirect.com/science/article/pii/S0167814012005294], 10.1016/j.radonc.2012.11.010, 23333015.
26. Bert C, Durante M. Motion in radiotherapy particle therapy. Phys Med Biol 2011, 56:113-144.